These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 19746590)

  • 1. Improvement of breast cancer cell detection by immunomagnetic enrichment.
    Krüger W; Tögel F; Rössing S; Kröger N; Zander AR
    Cytotherapy; 1999; 1(2):135-9. PubMed ID: 19746590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of preharvest tumor cell contamination in bone marrow or blood does not predict resultant tumor cell contamination of granulocyte colony-stimulating factor mobilized stem cells.
    Krüger W; Kröger N; Tögel F; Badbaran A; Renges H; Gieseking F; Gutensohn K; Jänicke F; Zander AR
    J Hematother Stem Cell Res; 2001 Apr; 10(2):303-7. PubMed ID: 11359677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of cancer cells in peripheral blood stem cells of women with breast cancer by RT-PCR and cell culture.
    Krüger WH; Stockschläder M; Hennings S; Aschenbrenner M; Gruber M; Gutensohn K; Löliger C; Gieseking F; Jonat W; Zander AR
    Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S18-20. PubMed ID: 8899163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction.
    Mapara MY; Körner IJ; Hildebrandt M; Bargou R; Krahl D; Reichardt P; Dörken B
    Blood; 1997 Jan; 89(1):337-44. PubMed ID: 8978310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy.
    Mohr M; Hilgenfeld E; Fietz T; Hoppe B; Koenigsmann M; Hoffmann M; Knauf WU; Cassens U; Sibrowski W; Kienast J; Thiel E; Berdel WE
    Clin Cancer Res; 1999 May; 5(5):1035-40. PubMed ID: 10353736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast tumor contamination of PBSC harvests: tumor depletion by positive selection of CD34(+) cells.
    Burgess J; Mills B; Griffith M; Mansour V; Weaver CH; Schwartzberg LS; Snyder EL; Krause DS; Yanovich S; Prilutskaya M; Umiel T; Moss TJ
    Cytotherapy; 2001; 3(4):285-94. PubMed ID: 12171717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative immunomagnetic purging of peripheral blood stem cell harvests from breast carcinoma patients reduces tumor cell contamination while not affecting hematopoietic recovery.
    Pedrazzoli P; Lanza A; Battaglia M; Da Prada GA; Zambelli A; Perotti C; Ponchio L; Salvaneschi L; Robustelli della Cuna G
    Cancer; 2000 Jun; 88(12):2758-65. PubMed ID: 10870058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour cell detection in G-CSF mobilised stem cell harvests of patients with breast cancer.
    Krüger W; Tögel F; Kröger N; Rössing S; Gieseking F; Gutensohn K; Lindner C; Jänicke F; Zander AR
    Med Oncol; 1999 Apr; 16(1):17-22. PubMed ID: 10382938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen.
    Schindlbeck C; Stellwagen J; Jeschke U; Karsten U; Rack B; Janni W; Jückstock J; Tulusan A; Sommer H; Friese K
    Clin Exp Metastasis; 2008; 25(3):233-40. PubMed ID: 18185913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral blood CD34+ cell immunomagnetic selection in breast cancer patients: effect on hematopoietic progenitor content and hematologic recovery after high-dose chemotherapy and autotransplantation.
    Cancelas JA; Querol S; Canals C; Picón M; Azqueta C; Solà C; Montes A; Amill B; Griera E; Inglés J; López JJ; Germà JR; García-López J
    Transfusion; 1998; 38(11-12):1063-70. PubMed ID: 9838939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo cytoreduction studies and cell sorting--enhanced tumor-cell detection in high-risk neuroblastoma patients: implications for leukapheresis strategies.
    Faulkner LB; Garaventa A; Paoli A; Tintori V; Tamburini A; Lacitignola L; Veltroni M; Lo Piccolo MS; Viscardi E; Milanaccio C; Tondo A; Spinelli S; Bernini G; De Bernardi B
    J Clin Oncol; 2000 Nov; 18(22):3829-36. PubMed ID: 11078496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomagnetic tumor cell selection--implications for the detection of disseminated cancer cells.
    Krüger W; Datta C; Badbaran A; Tögel F; Gutensohn K; Carrero I; Kröger N; Jänicke F; Zander AR
    Transfusion; 2000 Dec; 40(12):1489-93. PubMed ID: 11134569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support.
    Franklin WA; Shpall EJ; Archer P; Johnston CS; Garza-Williams S; Hami L; Bitter MA; Bast RC; Jones RB
    Breast Cancer Res Treat; 1996; 41(1):1-13. PubMed ID: 8932871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the content and subpopulations of CD3 and CD34 positive cells in bone marrow harvests and G-CSF-mobilized peripheral blood leukapheresis products from healthy adult donors.
    Hassan HT; Stockschläder M; Schleimer B; Krüger W; Zander AR
    Transpl Immunol; 1996 Dec; 4(4):319-23. PubMed ID: 8972563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD34(+) cell enrichment depletes atypical CD30(+) cells from PBPC grafts in patients with HD.
    Blystad AK; Torlakovic E; Holte H; Kvaløy S; Lenschow E; Kvalheim G
    Cytotherapy; 2001; 3(4):295-305. PubMed ID: 12171718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
    Lemoli RM; Cavo M; Fortuna A
    J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive and negative selection to reduce tumour contamination in peripheral blood stem cell harvests.
    Davies FE; Rawstron AC; Pratt G; Coupe R; Clarke D; Lubenko A; Short K; Perren TJ; Selby PJ; Maclennan S; Major K; Woodhead V; Robinson F; Child JA; Smith GM; Johnson PW; Morgan GJ
    Hematol Oncol; 2000 Sep; 18(3):111-20. PubMed ID: 11027980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.
    Roots-Weiss A; Papadimitriou C; Serve H; Hoppe B; Koenigsmann M; Reufi B; Oberberg D; Thiel E; Berdel WE
    Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor cell depletion of peripheral blood progenitor cells using positive and positive/negative selection in metastatic breast cancer.
    Preti RA; Lazarus HM; Winter J; Stadtmauer EA; Nadasi S; McMannis J; Karandish S; Jennis A; Goldberg SL; Pecora AL
    Cytotherapy; 2001; 3(2):85-95. PubMed ID: 12028831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast tumor contamination of peripheral blood stem cell harvests: increased sensitivity of detection using immunomagnetic enrichment.
    Umiel T; Prilutskaya M; Nguyen NH; Moss TJ; Schaeffer A; Burgess J; Griffith M; Mills B
    J Hematother Stem Cell Res; 2000 Dec; 9(6):895-904. PubMed ID: 11177603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.